Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol.

× No keyword cloud information.

11 in total

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors:
Journal: JAMA Date: 2001-05-16 Impact factor: 56.272

2. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

Authors: J G Fodor; J J Frohlich; J J Genest; P R McPherson
Journal: CMAJ Date: 2000-05-16 Impact factor: 8.262

3. Prediction of coronary heart disease using risk factor categories.

Authors: P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal: Circulation Date: 1998-05-12 Impact factor: 29.690

4. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors: J C LaRosa; J He; S Vupputuri
Journal: JAMA Date: 1999 Dec 22-29 Impact factor: 56.272

5. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study.

Authors: I Lemieux; B Lamarche; C Couillard; A Pascot; B Cantin; J Bergeron; G R Dagenais; J P Després
Journal: Arch Intern Med Date: 2001 Dec 10-24

6. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.

Authors: W P James; A Astrup; N Finer; J Hilsted; P Kopelman; S Rössner; W H Saris; L F Van Gaal
Journal: Lancet Date: 2000 Dec 23-30 Impact factor: 79.321

7. Treatment of obesity: need to focus on high risk abdominally obese patients.

Authors: J P Després; I Lemieux; D Prud'homme
Journal: BMJ Date: 2001-03-24

8. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

Authors: I Lemieux; A Pascot; C Couillard; B Lamarche; A Tchernof; N Alméras; J Bergeron; D Gaudet; G Tremblay; D Prud'homme; A Nadeau; J P Després
Journal: Circulation Date: 2000-07-11 Impact factor: 29.690

Review 9. HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study.

Authors: J P Després; I Lemieux; G R Dagenais; B Cantin; B Lamarche
Journal: Atherosclerosis Date: 2000-12 Impact factor: 5.162

10. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.

Authors: B Lamarche; A Tchernof; P Mauriège; B Cantin; G R Dagenais; P J Lupien; J P Després
Journal: JAMA Date: 1998-06-24 Impact factor: 56.272

2 in total

1. Risk factors for cardiovascular disease.

Authors: Giuseppe Lippi; Giancesare Guidi
Journal: CMAJ Date: 2002-03-19 Impact factor: 8.262

2. A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial.

Authors: Olivier F Bertrand; Paul Poirier; Josep Rodés-Cabau; Stéphane Rinfret; Lawrence Title; Vladimir Dzavik; Madhu Natarajan; Juan Angel; Nuria Batalla; Natalie Alméras; Olivier Costerousse; Robert De Larochellière; Louis Roy; Jean-Pierre Després
Journal: Can J Cardiol Date: 2009-09 Impact factor: 5.223

2 in total